H1N1 Vaccines Market Trends

Statistics for the 2023 & 2024 H1N1 Vaccines market trends, created by Mordor Intelligence™ Industry Reports. H1N1 Vaccines trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of H1N1 Vaccines Industry

This section covers the major market trends shaping the H1N1 Vaccines Market according to our research experts:

Intramuscular Vaccines Segment is Expected to Witness a Rapid Growth

An intramuscular injection is a procedure used to deliver a medication deep into the muscles which allows the medication to be absorbed into the bloodstream quickly. Intramuscular injections are absorbed faster than subcutaneous injections because muscles have a greater blood supply than the tissue present under the skin. Moreover, muscle tissue can also hold a larger volume of medication than subcutaneous tissue. According to the 2017 United Nations report, the global population is crossing the age of 60 at an annual rate of 3% which maximizes the risk of various diseases such as respiratory tract disorders and immune deficient diseases, thereby the risk for infection due to H1N1 virus rises.

The intramuscular vaccines segment holds a significant market share in the H1N1 vaccines market and is anticipated to show a similar trend over the forecast period. Rising incidences of swine flu and the need for H1N1 vaccination is increasing and  increased risk of respiratory diseases and immune-deficient diseases among the geriatric population are the key driving factors in the intramuscular vaccines segment.

H1N1 Vaccines Market key trend 1

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the H1N1 vaccines market due to increasing government initiatives for the prevention of H1N1 infection and improved research infrastructure in this region. According to the Centers for Disease Control (CDC), about 8 percent of the United States population gets sick from the flu. In addition, approximately 31.4 million people visit the doctor and 200,000 people end up in the hospital every flu season. Moreover, technological advancements in the vaccines field and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.

H1N1 Vaccines Market 2

H1N1 Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)